All updated as on -
From 2022-2030, the global Cell Analysis Market is predicted to grow from $17.8 billion at a CAGR of 10.5% to $42.11 billion. Examining and analysing individual cells in a material, typically human tissue, is what scientists call "cell analysis." Microscopy, cell culture, immunohistochemistry, flow cytometry, and imaging are just some of the methods that may be used in the process. Structure, function, and behaviour of cells can all be identified, measured, and studied with the help of cell analysis. It can be utilised for early diagnosis and treatment outcome assessment. Medical researchers rely heavily on cell analysis, which is also finding expanding application in biotechnology, drug discovery, and forensic science.
Increasing research activities, technological advancement, rising prevalence of chronic diseases, rising funding for life science research, growing demand for personalised medicines, advances in stem cell research, and growing awareness of cell-based therapies are all factors that are contributing to the market's expansion. Analysing cells involves dissecting them to determine their size, shape, structure, functions, and behaviour using a variety of tools and methods. Insights into biological processes, disease mechanisms, and therapeutic efficacy are just some of the many topics that can be illuminated by this type of investigation. Flow cytometry, microscopy, cell culture, and molecular biology are only few of the technologies used to analyse cells. Cell analysis is essential in many disciplines, from fundamental study to medication development and diagnostics to patient-specific treatment.
Cell Analysis Market Growth is primarily driven by the worldwide increase in chronic diseases such as autoimmune disease, cardiovascular disease, and neurological disorders. The examination of cells is a powerful tool in the fight against chronic diseases. Cell analysis is used to learn more about the genetic and molecular causes of chronic diseases and to find new ways to treat them. Analysis of cells is used to track therapies' efficacy and locate possible biomarkers that can foretell results. Better treatments and interventions for chronic diseases can be created by cell research of their underlying mechanisms. In 2022, the World Health Organisation (WHO) estimated that epilepsy, one of the most common neurological illnesses, affected about 50 million people worldwide. Additionally, developments in cell analysis are anticipated to be a prominent driver driving market expansion in the approaching years. Thanks to recent technological advances, automated cell analysis technologies are now available, capable of producing trustworthy data in a timely fashion. Automated solutions, for instance, can be employed for real-time patient monitoring while cutting the time and money spent on manual testing.
The Heart and Stroke Foundation of Canada reports that in 2018, over 1.6 million Canadians were diagnosed with heart disease. Fifty thousand people died from ischemic heart disease that year. Analysis of individual cells can shed light on the causes of ischemic heart disease and lead to the discovery of new diagnostic or prognostic biomarkers. Demand is forecast to climb in the coming years as heart disease cases continue to rise. The screening of compounds for neuroprotective qualities, the evaluation of the efficacy and safety of potential therapeutic candidates, and the optimisation of drug transport to the brain are all examples of how cell analysis is integral to the discovery and development of new treatments for PD. In the coming years, demand is expected to rise as a result of the rising prevalence of Parkinson's disease.
In order to better comprehend the intricacies involved in drug discovery, cell-based screening techniques have become increasingly popular. Moreover, the utilisation of cell-based assays in the drug discovery process has increased as a result of the vast amounts of data created by recent discoveries in cell biology, bioinformatics, molecular biology, genomics, and proteomics. Similarly, the Human Genome Project has provided a rich source of potential drug-screening targets. The development of cell-based assays for primary and secondary screening in drug discovery has been hastened by the recent explosion in pharmacological targets and drug leads.
The accuracy of cell analyses has been bolstered by the development of high-throughput screening (HTS) and high-content screening (HCS) methods. The price of instruments has increased dramatically as a result of these technological advancements. It's important to note that the complexity of the target molecule has a direct correlation with the time and money required for each HTS operation. The usage of such costly equipment has substantially increased the cost of producing biopharmaceuticals in biopharmaceutical companies.
Report Coverage
Global Cell Analysis research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cell Analysis report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cell Analysis competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cell Analysis market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cell Analysis market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cell Analysis market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Danaher Corporation, Becton, Dickinson and Company, Agilent Technologies, Inc., Illumina, Inc., Biomerieux SA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. , Qiagen N.V., Sartorius AG, Standard BioTools Inc.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Cell Analysis market based on the below-mentioned segments:
Global Cell Analysis Market, By Technique
Flow cytometry
Mass Spectrometry
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Others
Global Cell Analysis market, By Application
Oncology
Immunology
Cardiology
Genetic Disease
Stem Cells
Others
Global Cell Analysis Market, By End User
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Academic and Research Laboratories
Others
Global Cell Analysis market, Regional Analysis
Increasing research activities, technological advancement, rising prevalence of chronic diseases, rising funding for life science research, growing demand for personalised medicines, advances in stem cell research, and growing awareness of cell-based therapies are all factors that are contributing to the market's expansion. Analysing cells involves dissecting them to determine their size, shape, structure, functions, and behaviour using a variety of tools and methods. Insights into biological processes, disease mechanisms, and therapeutic efficacy are just some of the many topics that can be illuminated by this type of investigation. Flow cytometry, microscopy, cell culture, and molecular biology are only few of the technologies used to analyse cells. Cell analysis is essential in many disciplines, from fundamental study to medication development and diagnostics to patient-specific treatment.
Cell Analysis Market Growth is primarily driven by the worldwide increase in chronic diseases such as autoimmune disease, cardiovascular disease, and neurological disorders. The examination of cells is a powerful tool in the fight against chronic diseases. Cell analysis is used to learn more about the genetic and molecular causes of chronic diseases and to find new ways to treat them. Analysis of cells is used to track therapies' efficacy and locate possible biomarkers that can foretell results. Better treatments and interventions for chronic diseases can be created by cell research of their underlying mechanisms. In 2022, the World Health Organisation (WHO) estimated that epilepsy, one of the most common neurological illnesses, affected about 50 million people worldwide. Additionally, developments in cell analysis are anticipated to be a prominent driver driving market expansion in the approaching years. Thanks to recent technological advances, automated cell analysis technologies are now available, capable of producing trustworthy data in a timely fashion. Automated solutions, for instance, can be employed for real-time patient monitoring while cutting the time and money spent on manual testing.
The Heart and Stroke Foundation of Canada reports that in 2018, over 1.6 million Canadians were diagnosed with heart disease. Fifty thousand people died from ischemic heart disease that year. Analysis of individual cells can shed light on the causes of ischemic heart disease and lead to the discovery of new diagnostic or prognostic biomarkers. Demand is forecast to climb in the coming years as heart disease cases continue to rise. The screening of compounds for neuroprotective qualities, the evaluation of the efficacy and safety of potential therapeutic candidates, and the optimisation of drug transport to the brain are all examples of how cell analysis is integral to the discovery and development of new treatments for PD. In the coming years, demand is expected to rise as a result of the rising prevalence of Parkinson's disease.
In order to better comprehend the intricacies involved in drug discovery, cell-based screening techniques have become increasingly popular. Moreover, the utilisation of cell-based assays in the drug discovery process has increased as a result of the vast amounts of data created by recent discoveries in cell biology, bioinformatics, molecular biology, genomics, and proteomics. Similarly, the Human Genome Project has provided a rich source of potential drug-screening targets. The development of cell-based assays for primary and secondary screening in drug discovery has been hastened by the recent explosion in pharmacological targets and drug leads.
The accuracy of cell analyses has been bolstered by the development of high-throughput screening (HTS) and high-content screening (HCS) methods. The price of instruments has increased dramatically as a result of these technological advancements. It's important to note that the complexity of the target molecule has a direct correlation with the time and money required for each HTS operation. The usage of such costly equipment has substantially increased the cost of producing biopharmaceuticals in biopharmaceutical companies.
Report Coverage
Global Cell Analysis research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cell Analysis report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cell Analysis competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cell Analysis market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Danaher Corporation, Becton, Dickinson and Company, Agilent Technologies, Inc., Illumina, Inc., Biomerieux SA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. , Qiagen N.V., Sartorius AG, Standard BioTools Inc. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Cell Analysis Market from 2021 to 2030.
- Market Forecast for Cell Analysis Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Cell Analysis competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Cell Analysis
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cell Analysis market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cell Analysis market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Danaher Corporation, Becton, Dickinson and Company, Agilent Technologies, Inc., Illumina, Inc., Biomerieux SA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. , Qiagen N.V., Sartorius AG, Standard BioTools Inc.
Primary Target Market
- Market Players of Cell Analysis
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Cell Analysis market based on the below-mentioned segments:
Global Cell Analysis Market, By Technique
Flow cytometry
Mass Spectrometry
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Others
Global Cell Analysis market, By Application
Oncology
Immunology
Cardiology
Genetic Disease
Stem Cells
Others
Global Cell Analysis Market, By End User
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Academic and Research Laboratories
Others
Global Cell Analysis market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive cell analysis market market research and competitor analysis for your business to help you develop more profound insights into the cell analysis market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the cell analysis market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.